Earnings
see more| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.240 | ||||||
| REV | 827.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KDNY | Chinook Therapeutics | -3.52% | 650.1M |
Chinook Therapeutics Company Questions & Answers
How do I buy Chinook Therapeutics (KDNY) stock?
You can purchase shares of Chinook Therapeutics (NASDAQ: KDNY) through any online brokerage.
Who are Chinook Therapeutics's (KDNY) main competitors?
Other companies in Chinook Therapeutics’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immatics (NASDAQ:IMTX).
What is the target price for Chinook Therapeutics?
The latest price target for Chinook Therapeutics (NASDAQ: KDNY) was reported by Wedbush on 2021-01-06. The analyst firm set a price target for 28.00 expecting KDNY to rise to within 12 months (a possible 82.53% upside). 5 analyst firms have reported ratings in the last year.
How much is Chinook Therapeutics (KDNY) stock ?
The stock price for Chinook Therapeutics (NASDAQ: KDNY) is $15.34 last updated Mon Apr 19 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
When is the next Chinook Therapeutics (KDNY) dividend?
There are no upcoming dividends for Chinook Therapeutics.
When is Chinook Therapeutics (NASDAQ:KDNY) reporting earnings?
When is the upcoming split for KDNY?
There is no upcoming split for Chinook Therapeutics.